Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03137108
Other study ID # 2017-00053
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2017
Est. completion date November 12, 2019

Study information

Verified date October 2022
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Recently, a transcutaneous protocol of electrical spinal cord stimulation (tSCS) has been developed. It was suggested, that this method could be used to improve the therapy process after a spinal cord injury (SCI). The aim of this study is to investigate the immediate effects of tSCS with different stimulation modalities on voluntary motor control in patients with incomplete SCI.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date November 12, 2019
Est. primary completion date November 12, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with incomplete SCI - Chronic (= 12 months post-injury) or subacute (= 3 months post-injury) stage of recovery - Age: =18 years - Able to complete the 10mWT with walking aids as required but no physical assistance - Neurological level of SCI: above T12 - Preserved segmental and cutaneo-muscular reflexes in the lower limbs - Bodyweight > 20 kg and < 120 kg - Mini-Mental state examination score 6 (test only performed if cognitive deficits are suspected) Exclusion Criteria: - Any other neurological diseases - Current orthopedic problems - Premorbid major depression or psychosis - History of significant autonomic dysreflexia with treatment - Dermatological issues (e.g. decubitus) at the stimulation or harness attachment site (back, abdomen, upper legs) - Active implants (e.g. cardiac pacemaker, implanted drug pump) - Passive implants at vertebral level T9 or more caudal vertebrae (metal screws and plates for surgical stabilization of spinal fractures) - Malignant diseases - Heart insufficiency NYHA III-IV - Potential pregnancy (pregnancy test must be conducted before each session) - Unlikely to complete the intervention or return for follow-up - Participation in another training study - Contraindications for BWS training using the FLOAT (according the manual): - No responsiveness - Severe muscle contractures - Acute fractures - Osteoporosis or osteogenesis imperfecta - Body size shorter than 1 meter or taller than 2 meters

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcutaneous electrical spinal cord stimulation
Study intervention consists of the application of tSCS at three different frequencies (15 Hz, 30 Hz, 50 Hz) using the CE certified electrostimulator RehaMove 3. Stimulation will only be applied by an investigator during the two testing sessions. During the overground walking, the participants will be secured and assisted with the cable-driven body-weight support system FLOAT.

Locations

Country Name City State
Switzerland Universitätsklinik Balgrist Zürich

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Kinematic movement characteristics recorded with a motion capture system; Baseline and intervention of a specific task will be assessed directly after each other in a single session. All movement tasks will be split into 2 sessions within 2 weeks. The start of the first session is variable.